NEJM: Albuterol–Budesonide Fixed-Dose Combination Rescue Inhaler for Asthma
TAKE-HOME MESSAGE This multinational, phase III, double-blind, randomized, parallel-group, event-driven trial evaluated the efficacy and safety of albuterol–budesonide inhaler therapy for use as a rescue